Location History:
- Guangdong, CN (2021)
- Shenzhen, CN (2019 - 2023)
Company Filing History:
Years Active: 2019-2024
Title: Innovations of Xingye Ren in Pharmaceutical Chemistry
Introduction
Xingye Ren is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 6 patents to his name, Ren's work focuses on compounds that have the potential to treat various diseases.
Latest Patents
Ren's latest patents include a substituted pyrazolo[1,5-a]pyridine compound, which is designed for treating RET kinase-mediated diseases. This compound is represented by a specific formula and includes various forms such as tautomers, stereoisomers, and pharmaceutically acceptable salts. The pharmacokinetic properties of this compound are notably excellent, making it a promising candidate for therapeutic use. Another significant patent involves substituted pyrazole compounds that serve as tissue selective androgen receptor modulators (SARMs). These compounds are particularly aimed at treating prostate cancer and other conditions where androgen receptor antagonism is beneficial.
Career Highlights
Xingye Ren is currently associated with Shenzhen Targetrx, Inc., where he continues to innovate in the field of drug development. His work has been instrumental in advancing the understanding and application of new chemical entities in treating complex diseases.
Collaborations
Ren collaborates with notable colleagues such as Yihan Wang and Jian Jin, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Xingye Ren's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the industry. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes in various medical conditions.